Log in to save to my catalogue

Direct Reprogramming—The Future of Cardiac Regeneration?

Direct Reprogramming—The Future of Cardiac Regeneration?

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4581198

Direct Reprogramming—The Future of Cardiac Regeneration?

About this item

Full title

Direct Reprogramming—The Future of Cardiac Regeneration?

Publisher

Switzerland: MDPI AG

Journal title

International journal of molecular sciences, 2015-07, Vol.16 (8), p.17368-17393

Language

English

Formats

Publication information

Publisher

Switzerland: MDPI AG

More information

Scope and Contents

Contents

Today, the only available curative therapy for end stage congestive heart failure (CHF) is heart transplantation. This therapeutic option is strongly limited by declining numbers of available donor hearts and by restricted long-term performance of the transplanted graft. The disastrous prognosis for CHF with its restricted therapeutic options has l...

Alternative Titles

Full title

Direct Reprogramming—The Future of Cardiac Regeneration?

Authors, Artists and Contributors

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4581198

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4581198

Other Identifiers

ISSN

1422-0067,1661-6596

E-ISSN

1422-0067

DOI

10.3390/ijms160817368

How to access this item